Jadenu and Proteinuria aggravated - a phase IV clinical study of FDA data

Summary:

Proteinuria aggravated is reported as a side effect among people who take Jadenu (deferasirox), especially for people who are female, 2-9 old, have been taking the drug for 2 - 5 years also take Exjade, and have Aplasia pure red cell.

The phase IV clinical study analyzes which people have Proteinuria aggravated when taking Jadenu. It is created by eHealthMe based on reports of 4,173 people who have side effects when taking Jadenu from the FDA, and is updated regularly.

What is Jadenu?

Jadenu has active ingredients of deferasirox. eHealthMe is studying from 4,176 Jadenu users. Check the latest studies of Jadenu.

What is Proteinuria aggravated?

Proteinuria aggravated is found to be associated with 1,069 drugs and 381 conditions by eHealthMe. Check the latest studies of Proteinuria aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

4,173 people reported to have side effects when taking Jadenu.
Among them, 11 people (0.26%) have Proteinuria aggravated.

Could Jadenu cause Proteinuria aggravated?

Among these 11 people:

How long have people been on Jadenu when they have Proteinuria aggravated? *

What is the gender of people who have Proteinuria aggravated when taking Jadenu? *

female: 70 %
male: 30 %

What is the age of people who have Proteinuria aggravated when taking Jadenu? *

What are other drugs people take besides Jadenu? *

What are other side effects people have besides Proteinuria aggravated? *

Serum Ferritin Increased: 4 people, 36.36%
Yellow Skin: 3 people, 27.27%
Pneumonia: 3 people, 27.27%
Anaemia (lack of blood): 3 people, 27.27%
Back Pain: 3 people, 27.27%
Chest Pain: 3 people, 27.27%
Haemoglobin Decreased: 3 people, 27.27%
Pain: 3 people, 27.27%
Paleness (unusual lightness of skin colour): 3 people, 27.27%
Pleural Effusion (water on the lungs): 3 people, 27.27%

What are the existing conditions these people have? *

Iron Overload: 1 person, 9.09%
Aplastic Anemia: 1 person, 9.09%
Aplasia Pure Red Cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Jadenu and have Proteinuria aggravated?

- Check whether Proteinuria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Jadenu:

Jadenu (4,176 reports)

Browse all side effects of Jadenu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Proteinuria aggravated:

Proteinuria aggravated (1,069 drugs)

Browse all the conditions that are associated with Proteinuria aggravated:

Proteinuria aggravated (381 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on deferasirox (the active ingredients of Jadenu) and Jadenu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.